(NYSE: AORT) Artivion's forecast annual revenue growth rate of 10.35% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Artivion's revenue in 2025 is $388,537,000.On average, 2 Wall Street analysts forecast AORT's revenue for 2025 to be $17,939,731,415, with the lowest AORT revenue forecast at $17,882,966,766, and the highest AORT revenue forecast at $17,996,496,064. On average, 2 Wall Street analysts forecast AORT's revenue for 2026 to be $19,745,688,205, with the lowest AORT revenue forecast at $19,657,387,640, and the highest AORT revenue forecast at $19,833,988,770.
In 2027, AORT is forecast to generate $22,070,936,411 in revenue, with the lowest revenue forecast at $22,070,936,411 and the highest revenue forecast at $22,070,936,411.